Volume 62, Issue 2 pp. 193-196
Brief Communication

Cystatin C in cerebrospinal fluid and multiple sclerosis

Sara F. Hansson MSc

Sara F. Hansson MSc

Department of Clinical Neuroscience, University of Göteborg, Sahlgrenska University Hospital/Mölndal, Mölndal, Sweden

Search for more papers by this author
Anja Hviid Simonsen MSc

Anja Hviid Simonsen MSc

Memory Disorders Research Group, Department of Neurology, Copenhagen University Hospital, Copenhagen, Denmark

Search for more papers by this author
Henrik Zetterberg MD, PhD

Henrik Zetterberg MD, PhD

Department of Clinical Neuroscience, University of Göteborg, Sahlgrenska University Hospital/Mölndal, Mölndal, Sweden

Department of Clinical Chemistry and Transfusion Medicine, University of Göteborg, Sahlgrenska University Hospital, Göteborg, Sweden

Search for more papers by this author
Oluf Andersen MD, PhD

Oluf Andersen MD, PhD

Department of Neurology, University of Göteborg, Sahlgrenska University Hospital, Göteborg, Sweden

Search for more papers by this author
Sara Haghighi MD, PhD

Sara Haghighi MD, PhD

Department of Neurology, University of Göteborg, Sahlgrenska University Hospital, Göteborg, Sweden

Search for more papers by this author
Inger Fagerberg BSc

Inger Fagerberg BSc

Department of Clinical Chemistry and Transfusion Medicine, University of Göteborg, Sahlgrenska University Hospital, Göteborg, Sweden

Search for more papers by this author
Ulf Andréasson PhD

Ulf Andréasson PhD

Department of Clinical Neuroscience, University of Göteborg, Sahlgrenska University Hospital/Mölndal, Mölndal, Sweden

Search for more papers by this author
Ann Westman-Brinkmalm PhD

Ann Westman-Brinkmalm PhD

Department of Clinical Neuroscience, University of Göteborg, Sahlgrenska University Hospital/Mölndal, Mölndal, Sweden

Search for more papers by this author
Anders Wallin MD, PhD

Anders Wallin MD, PhD

Department of Clinical Neuroscience, University of Göteborg, Sahlgrenska University Hospital/Mölndal, Mölndal, Sweden

Search for more papers by this author
Ulla Rüetschi PhD

Ulla Rüetschi PhD

Department of Clinical Chemistry and Transfusion Medicine, University of Göteborg, Sahlgrenska University Hospital, Göteborg, Sweden

Search for more papers by this author
Kaj Blennow MD, PhD

Corresponding Author

Kaj Blennow MD, PhD

Department of Clinical Neuroscience, University of Göteborg, Sahlgrenska University Hospital/Mölndal, Mölndal, Sweden

Department of Clinical Chemistry and Transfusion Medicine, University of Göteborg, Sahlgrenska University Hospital, Göteborg, Sweden

Department of Clinical Neuroscience, University of Göteborg, Sahlgrenska University Hospital/Mölndal, S-431 80 Mölndal, SwedenSearch for more papers by this author
First published: 19 September 2007
Citations: 27

Abstract

Objective

A recent study using surface-enhanced laser desorption/ionization time-of-flight analysis of cerebrospinal fluid identified a 12.5kDa truncated isoform of cystatin C (CysC) as a specific biomarker for multiple sclerosis (MS).

Methods

Surface-enhanced laser desorption/ionization time-of-flight analysis of cerebrospinal fluid samples from 43 MS patients and 46 healthy control subjects.

Results

Full-length CysC (13.4kDa) concentration was similar in MS and control samples. The 12.5kDa CysC protein was produced from full-length CysC by N-terminal cleavage during storage at −20°C.

Interpretation

The 12.5kDa CysC isoform is a storage-related artifact and is not useful as a diagnostic marker for MS. Ann Neurol 2007;62:193–196

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me